Compound Detail
CHEMBL4583691
NAPORAFENIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL4583691 |
| Name | NAPORAFENIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | UEPXBTCUIIGYCY-UHFFFAOYSA-N |
9
Targets
26
Activities
3
Assay Types
26
PK Parameters
20
Publications
6
Known Names
3
Indications
1
Mechanisms
Molecular Properties
502.5
MW (Da)
3.93
ALogP
7
HBA
2
HBD
96.8
PSA (Ų)
0.51
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor | INHIBITOR | B-raf/RAF proto-oncogene serine/threonine-protein kinase | ✓ | ✓ |
Indications
Melanoma Carcinoma, Non-Small-Cell Lung Neoplasms
Activity Summary
IC50 18 meas. best 9.7
Kd 5 meas. best 8.89
EC50 3 meas. best 7.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | IC50 | 9.7 | 8.8671 | 0.2 | 7 |
| Unchecked CHEMBL612545 | IC50 | 9.7 | 9.42 | 0.2 | 2 |
| Serine/threonine-protein kinase B-raf CHEMBL5145 | IC50 | 9.4 | 8.5043 | 0.4 | 7 |
| Serine/threonine-protein kinase B-raf CHEMBL5145 | Kd | 8.89 | 8.89 | 1.3 | 1 |
| Epithelial discoidin domain-containing receptor 1 CHEMBL5319 | Kd | 8.74 | 8.74 | 1.8 | 1 |
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | Kd | 8.44 | 8.44 | 3.6 | 1 |
| Discoidin domain-containing receptor 2 CHEMBL5122 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | EC50 | 7.85 | 7.85 | 14.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | Kd | 7.85 | 7.85 | 14.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.8 | 6.8 | 160.0 | 1 |
| A-375 CHEMBL613859 | IC50 | 6.62 | 6.62 | 240.0 | 1 |
| Calu-6 CHEMBL614535 | EC50 | 6.55 | 6.55 | 280.0 | 1 |
| Serine/threonine-protein kinase A-Raf CHEMBL1169596 | IC50 | 6.38 | 6.38 | 414.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2160.71 | ng.hr.mL-1 | Mus musculus |
| AUC | 904.48 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 1557.72 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3976.2 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 12667.77 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 52515.23 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 108879.53 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 13.5 | mL.min-1.g-1 | Homo sapiens |
| CL | 19.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 31.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.5 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 1600.0 | nM | Mus musculus |
| Cmax | 500.0 | nM | Rattus norvegicus |
| Cmax | 400.0 | nM | Canis lupus familiaris |
| Cmax | 878.0 | nM | Rattus norvegicus |
| Cmax | 2347.0 | nM | Rattus norvegicus |
| Cmax | 8680.0 | nM | Rattus norvegicus |
| Cmax | 12671.0 | nM | Rattus norvegicus |
| F | 65.0 | % | Mus musculus |
| F | 38.0 | % | Rattus norvegicus |
| F | 79.0 | % | Canis lupus familiaris |
| T1/2 | 6.5 | hr | Homo sapiens |
| Tmax | 3.0 | hr | Rattus norvegicus |
| Tmax | 3.0 | hr | Rattus norvegicus |
| Tmax | 2.0 | hr | Rattus norvegicus |
| Tmax | 5.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine